Adage Capital Partners Gp, L.L.C. Tango Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,905,349 shares of TNGX stock, worth $39.9 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,905,349Holding current value
$39.9 Million% of portfolio
0.05%Shares
8 transactions
Others Institutions Holding TNGX
# of Institutions
122Shares Held
116MCall Options Held
245KPut Options Held
18.9K-
Trv Gp Iv, LLC Boston, MA16.9MShares$114 Million97.21% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$72.6 Million11.21% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$71.9 Million4.69% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.16MShares$61.9 Million0.21% of portfolio
-
Woodline Partners LP San Francisco, CA6.03MShares$40.8 Million0.18% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $595M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...